Yi-Bin Chen, MD, provides insight on treatment of steroid-refractory chronic GVHD with ruxolitinib.
EP. 1: Overview: A 42-Year-Old Woman With Moderate Steroid-Refractory Chronic GVHD
Yi-Bin Chen, MD, discusses the work-up, diagnosis, and treatment of a 42-year-old woman with moderate steroid-refractory chronic graft-versus-host disease (GVHD).
EP. 2: Risk Factors for Chronic GVHD and Steroid-Refractory Disease
A focused discussion on various risk factors for developing chronic GVHD and steroid-refractory disease.
EP. 3: Symptoms and Manifestations of Chronic GVHD
A comprehensive overview of the symptoms of and organs involved in chronic GVHD.
EP. 4: Early Diagnosis of Chronic GVHD and Tools for Severity Assessment
Insight on early diagnosis of chronic GVHD and the tools clinicians use to assess GVHD severity.
EP. 5: Treatment Options for Steroid-Refractory Chronic GVHD
Yi-Bin Chen, MD, discusses available treatment options for patients with steroid-refractory chronic GVHD.
EP. 6: Ruxolitinib Efficacy in Steroid-Refractory Chronic GVHD
A discussion of data from the REACH3 trial and real-world data on the efficacy of ruxolitinib in patients with steroid-refractory chronic GVHD.
EP. 7: Ruxolitinib Safety in Steroid-Refractory Chronic GVHD
A brief overview of safety and adverse events in the REACH3 trial of ruxolitinib in patients with steroid-refractory chronic GVHD.
EP. 8: Reflections on the Case and Risk Management for Chronic GVHD
Yi-Bin Chen, MD, reflects on the patient case and outlines strategies for educating and managing patients at risk of developing chronic GVHD.
EP. 9: Steroid-Refractory Chronic GVHD: Unmet Needs and Future Directions
Closing out his discussion, Yi-Bin Chen, MD, talks about unmet needs, ongoing clinical trials, emerging treatment options for patients with steroid-refractory chronic GVHD.
2 Commerce Drive Cranbury, NJ 08512